---
title: "Lumacaftor - Cystic fibrosis of the lung"
sidebar: mydoc_sidebar
permalink: lumacaftorcysticfibrosisofthelung.html
toc: false 
---

{% include image.html url="images/lumacaftorcysticfibrosisofthelung.png" file="lumacaftorcysticfibrosisofthelung.png" alt="lumacaftorcysticfibrosisofthelung" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C569105 | Lumacaftor | Drug |
| UniProt:P13569 | Cystic fibrosis transmembrane conductance regulator | Protein |
| MESH:D003550 | Cystic fibrosis of the lung | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lumacaftor | INCREASES STABILITY OF | Cystic Fibrosis Transmembrane Conductance Regulator |
| Cystic Fibrosis Transmembrane Conductance Regulator | DISRUPTED BY | Cystic Fibrosis Of The Lung |
|---------|-----------|---------|

Comment: :Lumacaftor is used to treat people with cystic fibrosis who are homozygous for the F508del mutation

Reference: [https://go.drugbank.com/drugs/DB09280#mechanism-of-action](https://go.drugbank.com/drugs/DB09280#mechanism-of-action){:target="_blank"}